Morphofunctional characterisation of axonal damage in different rat models of chemotherapy‐induced peripheral neurotoxicity: The role of nerve excitability testing
Journal of the Peripheral Nervous System · 2024-03 · 29 (1) · 47-57
DOI: 10.1111/jns.12607 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the Peripheral Nervous System, online erschienen am 15.12.2023. Verfasst von Alessia Chiorazzi und 9 weiteren Autor:innen. Beteiligte Einrichtung: Experimental Neurology Unit, School of Medicine and Surgery, Monza, Italy. Hauptthemen laut MEDLINE: Antineoplastic Agents, Peripheral Nervous System Diseases, Neurotoxicity Syndromes, Polyneuropathies. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Themen: Onkologische Pflege
Abstract (Originalsprache)
Background and Aims Chemotherapy‐induced peripheral neurotoxicity (CIPN) is a common and long‐lasting adverse event of several anticancer compounds, for which treatment has not yet been developed. To fill this gap, preclinical studies are warranted, exploiting highly translational outcome measure(s) to transfer data from bench to bedside. Nerve excitability testing (NET) enables to test in vivo axonal properties and can be used to monitor early changes leading to axonal damage.
Methods
We tested NET use in two different CIPN rat models: oxaliplatin (OHP) and paclitaxel (PTX). Animals (female) were chronically treated with either PTX or OHP and compared to respective control animals. NET was performed as soon as the first injection was administered. At the end of the treatment, CIPN onset was verified via a multimodal and robust approach: nerve conduction studies, nerve morphometry, behavioural tests and intraepidermal nerve fibre density.
Results
NET showed the typical pattern of axonal hyperexcitability in the 72 h following the first OHP administration, whereas it showed precocious signs of axonal damage in PTX animals. At the end of the month of treatment, OHP animals showed a pattern compatible with a mild axonal sensory polyneuropathy. Instead, PTX cohort was characterised by a rather severe sensory axonal polyneuropathy with minor signs of motor involvement.
Interpretation
NET after the first administration demonstrated the ongoing OHP‐related channelopathy, whereas in PTX cohort it showed precocious signs of axonal damage. Therefore, NET could be suggested as an early surrogate marker in clinical trials, to detect precocious changes leading to axonal damage.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Experimental Neurology Unit, School of Medicine and Surgery, Monza, Italy.
- NeuroMI (Milan Center for Neuroscience), Milan, Italy.
- Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy.
ORCID-Profile: Cristina Meregalli, Guido Cavaletti, Paola Alberti
Zitieren
APA
Chiorazzi, A., Canta, A., Carozzi, V. A., Meregalli, C., Pozzi, E., Ballarini, E., Rodriguez-Menendez, V., Marmiroli, P., Cavaletti, G., & Alberti, P. (2024). Morphofunctional characterisation of axonal damage in different rat models of chemotherapy‐induced peripheral neurotoxicity: The role of nerve excitability testing. Journal of the Peripheral Nervous System, 29(1), 47-57. https://doi.org/10.1111/jns.12607
Vancouver
Chiorazzi A, Canta A, Carozzi VA, Meregalli C, Pozzi E, Ballarini E, et al. Morphofunctional characterisation of axonal damage in different rat models of chemotherapy‐induced peripheral neurotoxicity: The role of nerve excitability testing. Journal of the Peripheral Nervous System. 2024;29(1):47-57. doi:10.1111/jns.12607
BibTeX
@article{Chiorazzi2024,
author = {Chiorazzi, Alessia and Canta, Annalisa and Carozzi, Valentina Alda and Meregalli, Cristina and Pozzi, Eleonora and Ballarini, Elisa and Rodriguez-Menendez, Virginia and Marmiroli, Paola and Cavaletti, Guido and Alberti, Paola},
title = {Morphofunctional characterisation of axonal damage in different rat models of chemotherapy‐induced peripheral neurotoxicity: The role of nerve excitability testing},
journal = {Journal of the Peripheral Nervous System},
year = {2024},
volume = {29},
number = {1},
pages = {47--57},
doi = {10.1111/jns.12607}
}
EUVIMED